Quantum BioPharma Ltd.
QNTM
$6.30
$0.060.96%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 1.85M | 3.32M | 2.42M | 1.98M | 1.47M |
| Depreciation & Amortization | 112.80K | 120.80K | 136.80K | 120.10K | 122.20K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 6.24M | 4.18M | 3.46M | 2.26M | 1.56M |
| Operating Income | -6.24M | -4.18M | -3.46M | -2.26M | -1.56M |
| Income Before Tax | -5.46M | -4.02M | -3.35M | -2.09M | -1.65M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -5.46M | -4.02M | -3.35M | -2.09M | -1.65M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 96.00K | 188.20K | 240.60K | 188.10K | 257.00K |
| Net Income | -5.36M | -3.83M | -3.11M | -1.90M | -1.39M |
| EBIT | -6.24M | -4.18M | -3.46M | -2.26M | -1.56M |
| EBITDA | -6.13M | -4.06M | -3.32M | -2.14M | -1.44M |
| EPS Basic | -2.70 | -4.17 | -4.85 | -3.12 | -2.30 |
| Normalized Basic EPS | -1.90 | -2.54 | -2.89 | -1.82 | -0.93 |
| EPS Diluted | -2.70 | -4.17 | -4.85 | -3.25 | -2.30 |
| Normalized Diluted EPS | -1.90 | -2.54 | -2.89 | -1.82 | -0.93 |
| Average Basic Shares Outstanding | 1.98M | 917.80K | 641.20K | 610.00K | 605.60K |
| Average Diluted Shares Outstanding | 1.98M | 917.80K | 641.20K | 610.00K | 605.60K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |